Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1961 2
1963 1
1964 3
1966 1
1967 1
1968 1
1969 1
1970 1
1971 1
1973 1
1974 1
1975 1
1976 2
1977 2
1978 2
1979 2
1981 3
1985 1
1986 3
1987 1
1988 2
1989 2
1991 7
1992 3
1993 11
1994 7
1995 12
1996 14
1997 13
1998 4
1999 9
2000 7
2001 13
2002 12
2003 6
2004 12
2005 12
2006 12
2007 16
2008 18
2009 21
2010 22
2011 30
2012 23
2013 20
2014 21
2015 26
2016 26
2017 28
2018 22
2019 20
2020 35
2021 37
2022 33
2023 29
2024 28
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

601 results

Results by year

Filters applied: . Clear all
Page 1
A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study.
Pinto-Marín Á, Trilla-Fuertes L, Miranda Poma J, Vasudev NS, García-Fernández E, López-Vacas R, Miranda N, Wilson M, López-Camacho E, Pertejo A, Dittmann A, Kunz L, Brown J, Pedroche-Just Y, Zapater-Moros A, de Velasco G, Castellano D, González-Peramato P, Espinosa E, Banks RE, Fresno Vara JÁ, Gámez-Pozo A. Pinto-Marín Á, et al. Among authors: espinosa e. Br J Cancer. 2025 May 7. doi: 10.1038/s41416-025-03008-2. Online ahead of print. Br J Cancer. 2025. PMID: 40335662
Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study.
Weichenthal M, Ellebaek E, Mangana J, Asher N, Gavrilova I, Kandolf L, Ugurel S, Hausschild A, Meier F, Leiter U, Livingstone E, Gebhardt C, Gutzmer R, Ruhlmann CH, Mahncke-Guldbrandt L, Haslund CA, Kopec S, Teterycz P, Bender M, Poudroux W, Muñoz-Couselo E, Berciano-Guerrero MA, Shalamanova G, DePalo DK, Brozić JM, Chiarion-Sileni V, Arance A, Ziogas D, Robert C, van de Velde AO, Gassama AA, Shapira R, BenBetzalel G, Grynberg S, Ramelyte E, Bertoldo F, DelPrete V, Gaudy-Marqueste C, Mohr P, Dummer R, Ascierto PA, Gogas H, Espinosa E, Lebbé C, Rutkowski P, Haanen J, Schadendorf D, Svane IM; EUMelaReg Consortium Members. Weichenthal M, et al. Among authors: espinosa e. Eur J Cancer. 2025 May 2;220:115339. doi: 10.1016/j.ejca.2025.115339. Epub 2025 Mar 7. Eur J Cancer. 2025. PMID: 40090216
Hemicellulose/PVA-based bioactive films for food packaging: Effect of the molecular weight of avocado pruning waste-derived hemicellulose on biocomposite properties.
Lucena A, Rincón E, de Moura Pereira PF, Jiménez-Quero A, Rodríguez A, Pérez-Rodríguez F, Espinosa E. Lucena A, et al. Among authors: espinosa e. Int J Biol Macromol. 2025 May;309(Pt 3):142982. doi: 10.1016/j.ijbiomac.2025.142982. Epub 2025 Apr 8. Int J Biol Macromol. 2025. PMID: 40210038 Free article.
Real-life evidence of encorafenib plus binimetinib in patients with unresectable advanced or metastatic BRAFV600-mutant melanoma in Spain: the BECARE (GEM-2002) trial.
Soria A, Sanchez Mauriño P, Serrano Domingo JJ, García Galindo R, Sequero S, Gutiérrez Sanz L, Crespo G, Díaz-Beveridge R, Puértolas T, López P, Fra Rodríguez J, López Castro R, Aguayo C, Valdivia J, Cunquero-Tomás AJ, Benítez G, Ayala de Miguel P, Espinosa E, Muñoz-Couselo E, Campos B, García Sánchez L, Cerezuela-Fuentes P. Soria A, et al. Among authors: espinosa e. Front Oncol. 2025 Feb 26;15:1466185. doi: 10.3389/fonc.2025.1466185. eCollection 2025. Front Oncol. 2025. PMID: 40078188 Free PMC article.
Tracheal Aspirate Metagenomics Reveals Association of Antibiotic Resistance with Nonpulmonary Sepsis Mortality.
Rodríguez-Pérez H, Ciuffreda L, Hernández-Beeftink T, Guillen-Guio B, Domínguez D, Corrales A, Espinosa E, Alcoba-Florez J, Lorenzo-Salazar JM, González-Montelongo R, Villar J, Flores C. Rodríguez-Pérez H, et al. Among authors: espinosa e. Am J Respir Cell Mol Biol. 2025 Feb;72(2):219-222. doi: 10.1165/rcmb.2024-0192LE. Am J Respir Cell Mol Biol. 2025. PMID: 39405475 Free PMC article. No abstract available.
Neoadjuvant or perioperative therapy for melanoma metastasis in clinical practice: an international survey.
Hauschild A, Garbe C, Ascierto PA, Demidov L, Dreno B, Dummer R, Eggermont A, Forsea AM, Gebhardt C, Gershenwald JE, Hamid O, Hoeller C, Kandolf L, Kaufmann R, Kirkwood JM, Lebbé C, Long GV, Malvehy J, Martin-Algarra S, McArthur G, Neyns B, Richtig E, Robert C, Schadendorf D, Scolyer R, Sondak VK, Wainstein A, Weichenthal M, Nuti P; Melanoma World Society Study Group. Hauschild A, et al. Lancet Oncol. 2025 Jan;26(1):12-14. doi: 10.1016/S1470-2045(24)00627-2. Lancet Oncol. 2025. PMID: 39756440 No abstract available.
Central Memory CD4 T Cells from Persons with HIV Accumulate DNA Content Defects During Proliferative Response.
Romero-Rodríguez DP, Romero-Rodríguez J, Cervantes-Mejía F, Olvera-García G, Pérez-Patrigeon S, Murakami-Ogasawara A, Romero-Mora K, Gómez-Palacio M, Reyes-Terán G, Jiang W, Espinosa E. Romero-Rodríguez DP, et al. Among authors: espinosa e. AIDS Res Hum Retroviruses. 2025 Jan;41(1):37-42. doi: 10.1089/aid.2024.0062. Epub 2024 Oct 28. AIDS Res Hum Retroviruses. 2025. PMID: 39466061 Free PMC article.
Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis.
Cerezuela-Fuentes P, Gonzalez-Cao M, Puertolas T, Manzano JL, Maldonado C, Yelamos O, Berciano-Guerrero MA, Martin-Liberal J, Muñoz-Couselo E, Espinosa E, Drozdowskyj A, Berrocal A, Soria A, Marquez-Rodas I, Martin-Algarra S, Quindos M, Puig S; Spanish Melanoma Group (GEM). Cerezuela-Fuentes P, et al. Among authors: espinosa e. Clin Transl Oncol. 2025 Jan;27(1):386-391. doi: 10.1007/s12094-024-03583-5. Epub 2024 Jul 1. Clin Transl Oncol. 2025. PMID: 38951438
Classification of anticancer drugs: an update with FDA- and EMA-approved drugs.
Ostios-Garcia L, Pérez DM, Castelo B, Herradón NH, Zamora P, Feliu J, Espinosa E. Ostios-Garcia L, et al. Among authors: espinosa e. Cancer Metastasis Rev. 2024 Dec;43(4):1561-1571. doi: 10.1007/s10555-024-10188-5. Epub 2024 Jul 5. Cancer Metastasis Rev. 2024. PMID: 38965194 Free PMC article. Review.
Neutrophils on the mast cell menu.
Espinosa E. Espinosa E. J Leukoc Biol. 2024 Nov 27;116(6):1217-1219. doi: 10.1093/jleuko/qiae221. J Leukoc Biol. 2024. PMID: 39378340
Alternative activation of mast cells by CD4+ T helper cells.
Leveque E, Battut L, Petitfils C, Valitutti S, Cenac N, Dietrich G, Espinosa E. Leveque E, et al. Among authors: espinosa e. J Leukoc Biol. 2024 Nov 4;116(5):1127-1141. doi: 10.1093/jleuko/qiae139. J Leukoc Biol. 2024. PMID: 38916515
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study.
Mortier L, Villabona L, Lawrence B, Arance A, Butler MO, Beylot-Barry M, Saiag P, Samimi M, Ascierto PA, Spada F, De Pontville M, Maio M, Berrocal A, Espinosa E, Capdevila J, Levin M, Das D, Krepler C, Grebennik D, Chiarion-Sileni V. Mortier L, et al. Among authors: espinosa e. Am J Clin Dermatol. 2024 Nov;25(6):987-996. doi: 10.1007/s40257-024-00885-w. Epub 2024 Oct 8. Am J Clin Dermatol. 2024. PMID: 39377880 Free PMC article. Clinical Trial.
Adjuvant Use of Pembrolizumab for Stage III Melanoma in a Real-World Setting in Europe.
Weichenthal M, Mangana J, Gavrilova I, Lugowska I, Shalamanova GK, Kandolf L, Chiarion-Sileni V, Mohr P, Karanikolova TS, Teterycz P, Espinosa E, Schnecko P, Cheng P, Bender M, Jiang S, Burke T, Ascierto PA, Gogas H, Rodas IM, Rutkowski P, Schadendorf D, Dummer R, For The EUMelaReg Consortium. Weichenthal M, et al. Among authors: espinosa e. Cancers (Basel). 2024 Oct 22;16(21):3558. doi: 10.3390/cancers16213558. Cancers (Basel). 2024. PMID: 39517999 Free PMC article.
Access to melanoma drugs in Spain: a cross-sectional survey.
Gonzalez-Cao M, Puertolas T, Manzano JL, Maldonado C, Yelamos O, Berciano-Guerrero MÁ, Cerezuela P, Martin-Liberal J, Muñoz-Couselo E, Espinosa E, Drozdowskyj A, Berrocal A, Soria A, Marquez-Rodas I, Martin-Algarra S, Quindos M, Puig S; Spanish Melanoma Group (GEM). Gonzalez-Cao M, et al. Among authors: espinosa e. Clin Transl Oncol. 2024 Oct;26(10):2572-2583. doi: 10.1007/s12094-024-03501-9. Epub 2024 May 16. Clin Transl Oncol. 2024. PMID: 38750345
The ecto-enzyme CD38 modulates CD4T cell immunometabolic responses and participates in HIV pathogenesis.
Díaz-Basilio F, Vergara-Mendoza M, Romero-Rodríguez J, Hernández-Rizo S, Escobedo-Calvario A, Fuentes-Romero LL, Pérez-Patrigeon S, Murakami-Ogasawara A, Gomez-Palacio M, Reyes-Terán G, Jiang W, Vázquez-Pérez JA, Marín-Hernández Á, Romero-Rodríguez DP, Gutiérrez-Ruiz MC, Viveros-Rogel M, Espinosa E. Díaz-Basilio F, et al. Among authors: espinosa e. J Leukoc Biol. 2024 Sep 2;116(3):440-455. doi: 10.1093/jleuko/qiae060. J Leukoc Biol. 2024. PMID: 38466822
Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63.
Martínez-Campelo L, Blanco-Verea A, López-Fernández T, Martínez-Monzonís A, Buño A, Mazón P, Zamora P, Norton N, Reddy JS, Velasco-Ruiz A, González-Neira A, Vulsteke C, Alonso-Gordoa T, Cruz R, Diz-de Almeida S, Carracedo A, González-Juanatey JR, López-Sendón J, Brion M; CardioTox registry investigators. Martínez-Campelo L, et al. Sci Rep. 2024 Aug 8;14(1):18413. doi: 10.1038/s41598-024-69064-5. Sci Rep. 2024. PMID: 39117733 Free PMC article.
Combining Desferriferrioxamine B and 1-Hydroxy-2-Piperidone ((PIPO)H) to Chelate Zirconium. Solution Structure of a Model Complex of the [89Zr]Zr-DFOcyclo*-mAb Radioimmunoconjugate.
Mangin F, Fonquernie O, Jewula P, Brandès S, Penouilh MJ, Bonnin Q, Vincent B, Espinosa E, Aubert E, Meyer M, Chambron JC. Mangin F, et al. Among authors: espinosa e. Chempluschem. 2024 Jul;89(7):e202400062. doi: 10.1002/cplu.202400062. Epub 2024 Apr 13. Chempluschem. 2024. PMID: 38613508
Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma.
Lorenzo-Sanz L, Lopez-Cerda M, da Silva-Diz V, Artés MH, Llop S, Penin RM, Bermejo JO, Gonzalez-Suarez E, Esteller M, Viñals F, Espinosa E, Oliva M, Piulats JM, Martin-Liberal J, Muñoz P. Lorenzo-Sanz L, et al. Among authors: espinosa e. Nat Commun. 2024 Jun 24;15(1):5352. doi: 10.1038/s41467-024-49718-8. Nat Commun. 2024. PMID: 38914547 Free PMC article.
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma.
Sacco JJ, Carvajal RD, Butler MO, Shoushtari AN, Hassel JC, Ikeguchi A, Hernandez-Aya L, Nathan P, Hamid O, Piulats JM, Rioth M, Johnson DB, Luke JJ, Espinosa E, Leyvraz S, Collins L, Holland C, Sato T. Sacco JJ, et al. Among authors: espinosa e. J Immunother Cancer. 2024 Jun 6;12(6):e009028. doi: 10.1136/jitc-2024-009028. J Immunother Cancer. 2024. PMID: 38844408 Free PMC article. Clinical Trial.
Hypotension prediction index guided goal-directed therapy to reduce postoperative acute kidney injury during major abdominal surgery: study protocol for a multicenter randomized controlled clinical trial.
Ripollés-Melchor J, Carrasco-Sánchez L, Tomé-Roca JL, Aldecoa C, Zorrilla-Vaca A, Lorente-Olazábal JV, Colomina MJ, Pérez A, Jiménez-López JI, Navarro-Pérez R, Abad-Gurumeta A, Monge-García MI; HYT Study Group. Ripollés-Melchor J, et al. Trials. 2024 Apr 29;25(1):288. doi: 10.1186/s13063-024-08113-w. Trials. 2024. PMID: 38685032 Free PMC article.
Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis.
Piulats JM, Watkins C, Costa-García M, Del Carpio L, Piperno-Neumann S, Rutkowski P, Hassel JC, Espinosa E, de la Cruz-Merino L, Ochsenreither S, Shoushtari AN, Orloff M, Salama AKS, Goodall HM, Baurain JF, Nathan P. Piulats JM, et al. Among authors: espinosa e. Ann Oncol. 2024 Mar;35(3):317-326. doi: 10.1016/j.annonc.2023.11.013. Epub 2023 Dec 2. Ann Oncol. 2024. PMID: 38048850 Free article. Clinical Trial.
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results.
Schmid P, Turner NC, Barrios CH, Isakoff SJ, Kim SB, Sablin MP, Saji S, Savas P, Vidal GA, Oliveira M, O'Shaughnessy J, Italiano A, Espinosa E, Boni V, White S, Rojas B, Freitas-Junior R, Chae Y, Bondarenko I, Lee J, Torres Mattos C, Martinez Rodriguez JL, Lam LH, Jones S, Reilly SJ, Huang X, Shah K, Dent R. Schmid P, et al. Among authors: espinosa e. Clin Cancer Res. 2024 Feb 16;30(4):767-778. doi: 10.1158/1078-0432.CCR-23-2084. Clin Cancer Res. 2024. PMID: 38060199 Free PMC article. Clinical Trial.
Improved Feedback Quantizer with Discrete Space Vector.
Veillon M, Espinosa E, Melin P, Mirzaeva G, Rivera M, Baier CR, Ramirez RO. Veillon M, et al. Among authors: espinosa e. Sensors (Basel). 2024 Jan 3;24(1):287. doi: 10.3390/s24010287. Sensors (Basel). 2024. PMID: 38203149 Free PMC article.
Efficacy of second and third lines of treatment in advanced soft tissue sarcomas: a real-world study.
Gutierrez-Sainz L, Martinez-Fdez S, Pedregosa-Barbas J, Peña J, Alameda M, Viñal D, Villamayor J, Martinez-Recio S, Perez-Wert P, Pertejo-Fernandez A, Gallego A, Martinez-Marin V, Zamora P, Espinosa E, Mendiola M, Feliu J, Redondo A. Gutierrez-Sainz L, et al. Among authors: espinosa e. Clin Transl Oncol. 2023 Dec;25(12):3519-3526. doi: 10.1007/s12094-023-03221-6. Epub 2023 Jun 17. Clin Transl Oncol. 2023. PMID: 37329429
Proenkephalin deletion in hematopoietic cells induces intestinal barrier failure resulting in clinical feature similarities with irritable bowel syndrome in mice.
Mas-Orea X, Rey L, Battut L, Bories C, Petitfils C, Abot A, Gheziel N, Wemelle E, Blanpied C, Motta JP, Knauf C, Barreau F, Espinosa E, Aloulou M, Cenac N, Serino M, Mouledous L, Fazilleau N, Dietrich G. Mas-Orea X, et al. Among authors: espinosa e. Commun Biol. 2023 Nov 16;6(1):1168. doi: 10.1038/s42003-023-05542-2. Commun Biol. 2023. PMID: 37968381 Free PMC article.
Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational study.
Manzano JL, Martin-Liberal J, Fernández-Morales LA, Benítez G, Medina Martínez J, Quindós M, García-Castaño A, Fernández O, Simo RV, Majem M, Bellido L, Ayala de Miguel P, Campos B, Espinosa E, Macías Cerrolaza JA, Gil-Arnaiz I, Lorente D, Rodriguez-Lescure A, Perez VN, López Castro R, Gramaje MG, Puértolas T, Rodriguez Moreno JF, Espasa Font L, Belaustegui Ferrández G, Cerezuela-Fuentes P. Manzano JL, et al. Among authors: espinosa e. Melanoma Res. 2023 Oct 1;33(5):388-397. doi: 10.1097/CMR.0000000000000888. Epub 2023 Mar 28. Melanoma Res. 2023. PMID: 36988401 Free PMC article.
Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.
Trilla-Fuertes L, Gámez-Pozo A, Prado-Vázquez G, López-Vacas R, Soriano V, Garicano F, Lecumberri MJ, Rodríguez de la Borbolla M, Majem M, Pérez-Ruiz E, González-Cao M, Oramas J, Magdaleno A, Fra J, Martín-Carnicero A, Corral M, Puértolas T, Ramos-Ruiz R, Dittmann A, Nanni P, Fresno Vara JÁ, Espinosa E. Trilla-Fuertes L, et al. Among authors: espinosa e. Cancers (Basel). 2023 Sep 3;15(17):4407. doi: 10.3390/cancers15174407. Cancers (Basel). 2023. PMID: 37686682 Free PMC article.
Special Issue "Lignocellulosic Biomass II".
Rodríguez A, Espinosa E, Martín C. Rodríguez A, et al. Among authors: espinosa e. Molecules. 2023 Aug 24;28(17):6230. doi: 10.3390/molecules28176230. Molecules. 2023. PMID: 37687061 Free PMC article.
Rethinking Theta/Beta Ratio in ADHD through Functional Data Analysis.
Bianchi L, Espinosa E, Lazzari J, Asnaghi R, Poles I, Clementi L, Santambrogio MD. Bianchi L, et al. Among authors: espinosa e. Annu Int Conf IEEE Eng Med Biol Soc. 2023 Jul;2023:1-4. doi: 10.1109/EMBC40787.2023.10340127. Annu Int Conf IEEE Eng Med Biol Soc. 2023. PMID: 38083088
Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patients.
Zapater-Moros A, Díaz-Beltrán L, Gámez-Pozo A, Trilla-Fuertes L, Lumbreras-Herrera MI, López-Camacho E, González-Olmedo C, Espinosa E, Zamora P, Sánchez-Rovira P, Fresno Vara JÁ. Zapater-Moros A, et al. Among authors: espinosa e. Metabolomics. 2023 Jun 21;19(7):60. doi: 10.1007/s11306-023-02024-8. Metabolomics. 2023. PMID: 37344702
Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study.
Coin A, Noale M, Gareri P, Trevisan C, Bellio A, Fini F, Abbatecola AM, Del Signore S, Malara A, Mossello E, Fumagalli S, Volpato S, Monzani F, Bellelli G, Zia G, Incalzi RA; GeroCovid Observational Working Group. Coin A, et al. Eur Geriatr Med. 2023 Jun;14(3):465-476. doi: 10.1007/s41999-023-00790-1. Epub 2023 May 19. Eur Geriatr Med. 2023. PMID: 37204681 Free PMC article.
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide.
Haas S, Camm JA, Harald D, Steffel J, Virdone S, Pieper K, Brodmann M, Schellong S, Misselwitz F, Kayani G, Kakkar AK; GARFIELD-AF Investigators. Haas S, et al. Clin Res Cardiol. 2023 Jun;112(6):759-771. doi: 10.1007/s00392-022-02079-y. Epub 2022 Sep 12. Clin Res Cardiol. 2023. PMID: 36094573
Sequence of therapies for advanced BRAFV600E/K melanoma.
Gonzalez-Cao M, Rosell R, Martin Algarra S, Puertolas T, Espinosa E. Gonzalez-Cao M, et al. Among authors: espinosa e. Ann Transl Med. 2023 Mar 31;11(6):270. doi: 10.21037/atm-23-165. Epub 2023 Feb 14. Ann Transl Med. 2023. PMID: 37082692 Free PMC article. No abstract available.
MiR-422a promotes adipogenesis via MeCP2 downregulation in human bone marrow mesenchymal stem cells.
Giuliani A, Sabbatinelli J, Amatori S, Graciotti L, Silvestrini A, Matacchione G, Ramini D, Mensà E, Prattichizzo F, Babini L, Mattiucci D, Busilacchi EM, Bacalini MG, Espinosa E, Lattanzio F, Procopio AD, Olivieri F, Poloni A, Fanelli M, Rippo MR. Giuliani A, et al. Among authors: espinosa e. Cell Mol Life Sci. 2023 Feb 27;80(3):75. doi: 10.1007/s00018-023-04719-6. Cell Mol Life Sci. 2023. PMID: 36847916 Free PMC article.
Chemically diverse activity-based probes with unexpected inhibitory mechanisms targeting trypsin-like serine proteases.
Ramos-Llorca A, Decraecker L, Cacheux VMY, Zeiburlina I, De Bruyn M, Battut L, Moreno-Cinos C, Ceradini D, Espinosa E, Dietrich G, Berg M, De Meester I, Van Der Veken P, Boeckxstaens G, Lambeir AM, Denadai-Souza A, Augustyns K. Ramos-Llorca A, et al. Among authors: espinosa e. Front Chem. 2023 Jan 5;10:1089959. doi: 10.3389/fchem.2022.1089959. eCollection 2022. Front Chem. 2023. PMID: 36688031 Free PMC article.
Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial.
Albanell J, Pérez-García JM, Gil-Gil M, Curigliano G, Ruíz-Borrego M, Comerma L, Gibert J, Bellet M, Bermejo B, Calvo L, de la Haba J, Espinosa E, Minisini AM, Quiroga V, Santaballa Bertran A, Mina L, Bellosillo B, Rojo F, Menéndez S, Sampayo-Cordero M, Popa C, Malfettone A, Cortés J, Llombart-Cussac A. Albanell J, et al. Among authors: espinosa e. Clin Cancer Res. 2023 Jan 4;29(1):67-80. doi: 10.1158/1078-0432.CCR-22-1281. Clin Cancer Res. 2023. PMID: 36165912 Free PMC article. Clinical Trial.
Proteomics Characterization of Clear Cell Renal Cell Carcinoma.
Miranda-Poma J, Trilla-Fuertes L, López-Vacas R, López-Camacho E, García-Fernández E, Pertejo A, Lumbreras-Herrera MI, Zapater-Moros A, Díaz-Almirón M, Dittmann A, Fresno Vara JÁ, Espinosa E, González-Peramato P, Pinto-Marín Á, Gámez-Pozo A. Miranda-Poma J, et al. Among authors: espinosa e. J Clin Med. 2023 Jan 3;12(1):384. doi: 10.3390/jcm12010384. J Clin Med. 2023. PMID: 36615183 Free PMC article.
Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma.
Trilla-Fuertes L, Gámez-Pozo A, Prado-Vázquez G, López-Vacas R, Zapater-Moros A, López-Camacho E, Lumbreras-Herrera MI, Soriano V, Garicano F, Lecumberri MJ, Rodríguez de la Borbolla M, Majem M, Pérez-Ruiz E, González-Cao M, Oramas J, Magdaleno A, Fra J, Martín-Carnicero A, Corral M, Puértolas T, Ramos R, Fresno Vara JÁ, Espinosa E. Trilla-Fuertes L, et al. Among authors: espinosa e. Int J Mol Sci. 2023 Jan 2;24(1):801. doi: 10.3390/ijms24010801. Int J Mol Sci. 2023. PMID: 36614248 Free PMC article.
A genome-wide association study of survival in patients with sepsis.
Hernandez-Beeftink T, Guillen-Guio B, Lorenzo-Salazar JM, Corrales A, Suarez-Pajes E, Feng R, Rubio-Rodríguez LA, Paynton ML, Cruz R, García-Laorden MI, Prieto-González M, Rodríguez-Pérez A, Carriedo D, Blanco J, Ambrós A, González-Higueras E, Espinosa E, Muriel A, Tamayo E, Martin MM, Lorente L, Domínguez D, de Lorenzo AG, Giannini HM, Reilly JP, Jones TK, Añón JM, Soro M, Carracedo Á, Wain LV, Meyer NJ, Villar J, Flores C; Genetics of Sepsis (GEN-SEP) Network. Hernandez-Beeftink T, et al. Among authors: espinosa e. Crit Care. 2022 Nov 5;26(1):341. doi: 10.1186/s13054-022-04208-5. Crit Care. 2022. PMID: 36335405 Free PMC article.
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial.
Carvajal RD, Butler MO, Shoushtari AN, Hassel JC, Ikeguchi A, Hernandez-Aya L, Nathan P, Hamid O, Piulats JM, Rioth M, Johnson DB, Luke JJ, Espinosa E, Leyvraz S, Collins L, Goodall HM, Ranade K, Holland C, Abdullah SE, Sacco JJ, Sato T. Carvajal RD, et al. Among authors: espinosa e. Nat Med. 2022 Nov;28(11):2364-2373. doi: 10.1038/s41591-022-02015-7. Epub 2022 Oct 13. Nat Med. 2022. PMID: 36229663 Free PMC article. Clinical Trial.
Epicutaneous allergen immunotherapy induces a profound and selective modulation in skin dendritic-cell subsets.
Laoubi L, Lacoffrette M, Valsesia S, Lenief V, Guironnet-Paquet A, Mosnier A, Dubois G, Cartier A, Monti L, Marvel J, Espinosa E, Malissen B, Henri S, Mondoulet L, Sampson HA, Nosbaum A, Nicolas JF, Dioszeghy V, Vocanson M. Laoubi L, et al. Among authors: espinosa e. J Allergy Clin Immunol. 2022 Nov;150(5):1194-1208. doi: 10.1016/j.jaci.2022.05.025. Epub 2022 Jun 30. J Allergy Clin Immunol. 2022. PMID: 35779666
Electrical dyssynchrony mapping and cardiac resynchronization therapy.
Bank AJ, Brown CD, Burns KV, Espinosa EA, Harbin MM. Bank AJ, et al. Among authors: espinosa ea. J Electrocardiol. 2022 Sep-Oct;74:73-81. doi: 10.1016/j.jelectrocard.2022.08.006. Epub 2022 Aug 27. J Electrocardiol. 2022. PMID: 36055070 Free article.
Fertility sparing treatment in patients with endometrial cancer (FERT-ENC): a multicentric retrospective study from the Spanish Investigational Network Gynecologic Oncology Group (SPAIN-GOG).
Lago V, Marina T, Laseca Modrego M, Gil-Ibañez B, Rodriguez JR, Domingo J, Minig L, Padilla-Iserte P, Arencibia Sánchez O, Sala Ferichola M, Munmanny M, Martín Salamanca B, Iacoponi S, Cabrera S, Coronado P, Utrilla-Layna J, Bataller Á, Fiol G, Corbalán S, Espinosa E, Gil-Moreno A, Domingo S; Spanish Society of Gynecology and Obstetrics Spanish Investigational Network Gynecologic Oncology Group (SPAIN-GOG). Lago V, et al. Among authors: espinosa e. Arch Gynecol Obstet. 2022 Sep;306(3):821-828. doi: 10.1007/s00404-021-06375-2. Epub 2022 Feb 4. Arch Gynecol Obstet. 2022. PMID: 35122158
Comparison of 2-Weekly and 3-Weekly Dosing of Docetaxel in Metastatic Prostate Cancer.
Martinez-Recio S, Perez-Wert JP, Martinez-Fdez S, Jimenez-Bou D, Ruiz-Gutierrez I, Peña J, Pertejo A, Espinosa E, Pinto A. Martinez-Recio S, et al. Among authors: espinosa e. Clin Genitourin Cancer. 2022 Aug;20(4):363-370. doi: 10.1016/j.clgc.2022.02.009. Epub 2022 Feb 24. Clin Genitourin Cancer. 2022. PMID: 35317987
N-Iodosaccharin-pyridine co-crystal system under pressure: experimental evidence of reversible twinning.
Vijayakumar-Syamala V, Aubert E, Deutsch M, Wenger E, Dhaka A, Fourmigué M, Nespolo M, Espinosa E. Vijayakumar-Syamala V, et al. Among authors: espinosa e. Acta Crystallogr B Struct Sci Cryst Eng Mater. 2022 Jun 1;78(Pt 3 Pt 2):436-449. doi: 10.1107/S2052520622002542. Epub 2022 Apr 29. Acta Crystallogr B Struct Sci Cryst Eng Mater. 2022. PMID: 35702961
COVID-19 as a Paradigmatic Model of the Heterogeneous Disease Presentation in Older People: Data from the GeroCovid Observational Study.
Trevisan C, Remelli F, Fumagalli S, Mossello E, Okoye C, Bellelli G, Coin A, Malara A, Gareri P, Monzani F, Del Signore S, Zia G, Antonelli Incalzi R, Volpato S; GeroCovid Acute Ward Working Group. Trevisan C, et al. Rejuvenation Res. 2022 Jun;25(3):129-140. doi: 10.1089/rej.2021.0063. Epub 2022 Jun 6. Rejuvenation Res. 2022. PMID: 35570723
Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project).
Bernabei R, Landi F, Calvani R, Cesari M, Del Signore S, Anker SD, Bejuit R, Bordes P, Cherubini A, Cruz-Jentoft AJ, Di Bari M, Friede T, Gorostiaga Ayestarán C, Goyeau H, Jónsson PV, Kashiwa M, Lattanzio F, Maggio M, Mariotti L, Miller RR, Rodriguez-Mañas L, Roller-Wirnsberger R, Rýznarová I, Scholpp J, Schols AMWJ, Sieber CC, Sinclair AJ, Skalska A, Strandberg T, Tchalla A, Topinková E, Tosato M, Vellas B, von Haehling S, Pahor M, Roubenoff R, Marzetti E; SPRINTT consortium. Bernabei R, et al. BMJ. 2022 May 11;377:e068788. doi: 10.1136/bmj-2021-068788. BMJ. 2022. PMID: 35545258 Free PMC article. Clinical Trial.
Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancer.
López-Camacho E, Trilla-Fuertes L, Gámez-Pozo A, Dapía I, López-Vacas R, Zapater-Moros A, Lumbreras-Herrera MI, Arias P, Zamora P, Vara JÁF, Espinosa E. López-Camacho E, et al. Among authors: espinosa e. Biomed Pharmacother. 2022 May;149:112844. doi: 10.1016/j.biopha.2022.112844. Epub 2022 Mar 23. Biomed Pharmacother. 2022. PMID: 35339109 Free article.
Comparison of the Anti-inflammatory Properties of Two Nicotinic Acetylcholine Receptor Ligands, Phosphocholine and pCF3-diEPP.
Richter K, Papke RL, Stokes C, Roy DC, Espinosa ES, Wolf PMK, Hecker A, Liese J, Singh VK, Padberg W, Schlüter KD, Rohde M, McIntosh JM, Morley BJ, Horenstein NA, Grau V, Simard AR. Richter K, et al. Among authors: espinosa es. Front Cell Neurosci. 2022 Mar 31;16:779081. doi: 10.3389/fncel.2022.779081. eCollection 2022. Front Cell Neurosci. 2022. PMID: 35431807 Free PMC article.
Admixture Mapping of Sepsis in European Individuals With African Ancestries.
Hernandez-Beeftink T, Marcelino-Rodríguez I, Guillen-Guio B, Rodríguez-Pérez H, Lorenzo-Salazar JM, Corrales A, Díaz-de Usera A, González-Montelongo R, Domínguez D, Espinosa E, Villar J, Flores C. Hernandez-Beeftink T, et al. Among authors: espinosa e. Front Med (Lausanne). 2022 Mar 8;9:754440. doi: 10.3389/fmed.2022.754440. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35345767 Free PMC article.
Molecular characterization of triple negative breast cancer formaldehyde-fixed paraffin-embedded samples by data-independent acquisition proteomics.
García-Adrián S, Trilla-Fuertes L, Gámez-Pozo A, Chiva C, López-Vacas R, López-Camacho E, Zapater-Moros A, Lumbreras-Herrera MI, Hardisson D, Yébenes L, Zamora P, Sabidó E, Fresno Vara JÁ, Espinosa E. García-Adrián S, et al. Among authors: espinosa e. Proteomics. 2022 Feb;22(3):e2100110. doi: 10.1002/pmic.202100110. Epub 2021 Oct 27. Proteomics. 2022. PMID: 34624180
Prediction of Chemotoxicity, Unplanned Hospitalizations and Early Death in Older Patients with Colorectal Cancer Treated with Chemotherapy.
Feliu J, Espinosa E, Basterretxea L, Paredero I, Llabrés E, Jiménez-Munárriz B, Antonio-Rebollo M, Losada B, Pinto A, Custodio AB, Del Mar Muñoz M, Gómez-Mediavilla J, Torregrosa MD, Soler G, Cruz P, Higuera O, Molina-Garrido MJ. Feliu J, et al. Among authors: espinosa e. Cancers (Basel). 2021 Dec 28;14(1):127. doi: 10.3390/cancers14010127. Cancers (Basel). 2021. PMID: 35008291 Free PMC article.
Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial.
Gonzalez-Cao M, Mayo de Las Casas C, Oramas J, Berciano-Guerrero MA, de la Cruz L, Cerezuela P, Arance A, Muñoz-Couselo E, Espinosa E, Puertolas T, Diaz Beveridge R, Ochenduszko S, Villanueva MJ, Basterretxea L, Bellido L, Rodriguez D, Campos B, Montagut C, Drozdowskyj A, Molina MA, Lopez-Martin JA, Berrocal A. Gonzalez-Cao M, et al. Among authors: espinosa e. Nat Commun. 2021 Dec 1;12(1):7008. doi: 10.1038/s41467-021-26572-6. Nat Commun. 2021. PMID: 34853302 Free PMC article. Clinical Trial.
601 results